A simple phenotypic method for differentiation between acquired and chromosomal AmpC β-lactamases in Escherichia coli

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 24, Issue 6, 2006, Pages 370-372

  Mirelis, Beatriz ^a,b   Rivera, Alba ^a,b   Miró, Elisenda ^a   Mesa, Raúl J ^a,b   Navarro, Ferran ^a,b   Coll, Pere ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

ACC; AmpC lactamase; CMY; DHA; Phenotypic detection

Indexed keywords

AZTREONAM; BETA LACTAMASE AMPC; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CLOXACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM DETECTION; BACTERIUM ISOLATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG INHIBITION; ESCHERICHIA COLI; GENE SEQUENCE; GENOTYPE; HALO EFFECT; HUMAN; KLEBSIELLA PNEUMONIAE; METHODOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; SENSITIVITY AND SPECIFICITY;

EID: 33746515062     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13089690     Document Type: Article

References (11)

1. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother. 2002;46(1):1-11.
2. Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Doi Y, et al. Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol. 2005;43:2551-8.
3. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol. 2000;38:1791-6.
4. National Committee for Clinical Laboratoty Standards. Performance standards for antimicrobial disk susceptibility tests-Eighth informational supplement. NCCLS, Wayne, Pa, USA: Aproved standard M2-A8.; 2003.
5. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10:867-78.
6. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40:2153-62.
7. Miró E, Mirelis B, Navarro F, Matas L, Giménez M, Rabaza C. Escherichia coli producing an ACC-1 class C β-lactamase isolated in Barcelona, Spain. Antimicrob Agents Chemother. 2005;49:866-7.
8. Navarro F, Pérez-Trallero E, Marimón JM, Aliaga R, Gomáriz M, Mirelis B. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother. 2001;48:383-9.
9. Yan JJ, Ko WC, Jung YC, Chuang CL, Wu JJ. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J Clin Microbiol. 2002;40:3121-6.
10. Bidet P, Verdet C, Gautier V, Bingen E, Arlet G. First description of DHA-1 ampC β-lactamase in Proteus mirabilis. Clin Microbiol Infect. 2005;11:591-2.
11. Rhimi-Mahjoubi F, Bernier M, Arlet G, Jemaa ZB, Jouve P, Hammami A, et al. Mise en évidence de la céphalosporinase plasmidique ACC-1 dans différentes entérobactéries (Klebsiella pneumoniae, Proteus mirabilis, Salmonella) isolées dans un hôpital tunisien (Sfax 1997-2000). Pathol Biol (Paris). 2002;50:7-11.